Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, BioDlink International Co's Enterprise Value is HK$2,980.5 Mil.
BioDlink International Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-29.8 Mil. Therefore, BioDlink International Co's EV-to-FCF for today is -99.86.
The historical rank and industry rank for BioDlink International Co's EV-to-FCF or its related term are showing as below:
HKSE:01875'
s EV-to-FCF Range Over the Past 10 Years
Min: -238.76 Med: -6.49 Max: -1.55
Current: -99.86
During the past 9 years, the highest EV-to-FCF of BioDlink International Co was -1.55. The lowest was -238.76. And the median was -6.49.
HKSE:01875's EV-to-FCF is ranked worse than 100% of 319
companies
in the Biotechnology industry
Industry Median: 18.3
vs HKSE:01875: -99.86
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
BioDlink International Co (HKSE:01875) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
BioDlink International Co's PE Ratio (TTM) for today is calculated as:
BioDlink International Co's share price for today is HK$4.02.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. BioDlink International Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-0.155.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
BioDlink International Co EV-to-FCF Related Terms
BioDlink International Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01875 vs VRTX, REGN, RVMD: EV-to-FCF Comparison
For the Biotechnology subindustry, BioDlink International Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioDlink International Co EV-to-FCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BioDlink International Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where BioDlink International Co's EV-to-FCF falls into.
BioDlink International Co's current Enterprise Value is HK$2,980.5 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. BioDlink International Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-29.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioDlink International Co (HKSE:01875) has a EV-to-FCF of -99.86 as of Aug. 23, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on BioDlink International Co and its competitors. According to the industry distribution chart, BioDlink International Co ranks #999999 out of 319 companies in the Biotechnology industry.
Is BioDlink International Co's EV-to-FCF too high?
BioDlink International Co's current EV-to-FCF is -99.86. Based on the distribution chart, BioDlink International Co ranks #999999 out of 319 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, BioDlink International Co has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does BioDlink International Co's EV-to-FCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BioDlink International Co ranks #999999 out of 319 companies for EV-to-FCF. This places BioDlink International Co in the lower half of its industry. The industry median EV-to-FCF is 18.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 18.30, based on 319 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on BioDlink International Co and its competitors. For the Biotechnology industry, the median EV-to-FCF is 18.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioDlink International Co's current EV-to-FCF is -99.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioDlink International Co stock overvalued right now?
Based on GuruFocus' analysis, BioDlink International Co (HKSE:01875) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$1.47, compared to a current price of HK$4.02 — trading 173.5% above its estimated fair value. The current EV-to-FCF is -99.86. BioDlink International Co's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For BioDlink International Co (HKSE:01875), the current EV-to-FCF is -99.86 as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BioDlink International Co (HKSE:01875) Overvalued in 2026?
Based on GuruFocus' analysis, BioDlink International Co stock appears to be overvalued.
The current stock price of HK$4.02 is trading 173.5% above its estimated GF Value™ of HK$1.47.
GuruFocus considers BioDlink International Co to be Significantly Overvalued.
Key valuation signals for HKSE:01875:
EV-to-FCF: -99.86
GF Value™: HK$1.47 vs. price of HK$4.02 (173.5% above fair value)
No single metric tells the full story. See the HKSE:01875 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BioDlink International Co Ltd is an investment holding company. The Company is mainly engaged in research and development (R&D), manufacturing, and marketing of anti-tumor drugs, contract development and manufacturing organization (CDMO), contract manufacturing organization (CMO) business and license-out of self-developed biological drugs. The company has presence in Mainland China, and Others. The company's services includes ADC R&D Service Platform, Chemical based conjugation process development, Developability assessment for drug product, Drug substance analysis, Antibody Manufacturing, Drug product analysis, etc.
62GF Score
Get the complete analysis for HKSE:01875
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01875 has been successfully added to your 
